Abstract CT259: Comprehensive humoral and cellular immune assessments to SARS-CoV-2 (wild type, delta and omicron) following two- and three-dose vaccination schedule in a large adult cancer population: SerOzNET study: placeholder abstract
Segelov, Eva, Body, Amy, Luong, Vi, Lopez, Veronica Aedo, Lal, Luxi, Abdulla, Hesham, Turville, Stuart, Niang, Zin, Opat, Stephen, McCuaig, Robert, Lineburg, Katie, Rao, Sudha, Smith, Corey, MacIntyre, Raina, Ahern, Elizabeth
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Get full text
Journal Article
Abstract CT567: Comprehensive measures of COVID-19 vaccine efficacy in adolescent cancer patients: Results from SerOzNET
Segelov, Eva, Body, Amy, Turville, Stuart, Smith, Corey, Lineburg, Katie, Rao, Sudha, McCuaig, Robert, Opat, Stephen, Niang, Zin, Lal, Luxi, Luong, Vi, Abdulla, Hesham, Lopez, Veronica Aedo, Padhye, Bhavna, Bolanos, Noemi Fuentes, Anazodo, Antoinette, MacIntyre, Raina, Downie, Peter, O'Brien, Tracey, Ahern, Elizabeth
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Get full text
Journal Article